维普中文期刊产品整合服务
59篇 您的检索式:作者名="Narin R"
    题名 作者 年代 出处 被引量
1Effect of sodium tungstate on visual evoked potentials in diabetic rats显示文摘AIM: To evaluate the effect of sodium tungstate on visual evoked potentials(VEPs) in diabetic rats.· METHODS: Wistar rats were randomly divided into three groups as normal control, diabetic control and diabetic rats treated with sodium tungstate. Diabetes was induced by single intraperitoneal injection of streptozotocin(50 mg/kg). Sodium tungstate [40 mg/(kg·d)]was administered for 12 wk and then VEPs were recorded.Additionally, thiobarbituric acid reactive substance(TBARS) levels were measured in brain tissues.·RESULTS: The latencies of P1, N1, P2, N2 and P3 waves were significantly prolonged in diabetic rats compared with control group. Diabetes mellitus caused an increase in the lipid peroxidation process that was accompanied by changes in VEPs. However, prolonged latencies of VEPs for all components returned to control levels in sodium tungstate-treated group. The treatment of sodium tungstate significantly decreased brain TBARS levels and depleted the prolonged latencies of VEP components compared with diabetic control group.· CONCLUSION: Sodium tungstate shows protective effects on visual pathway in diabetic rats, and it can be worthy of further study for potential use.Mehmet Bulut Bariszgür Dnmez Nihai ztürk Gksum Basaranlar Ceren Kencebay Manas Narin Derin Semir zdemir 2016International Journal of Ophthalmology(English edition)2016,9,5:2
2Simple and mixed acid-base disorders:a practical approach (baltimore)显示文摘NARINS R G EMMETT M 1980Medicin1980,59,3:1
3A randomized, double-blind, multicenter comparison of the efficacy and lolerability of Restylane versus Zyplast for the correction of nasolabial folds 显示文摘NARINS R S BRANDT F LEYDEN J 2003Dennatol Surg2003,29,6:1
4Patents as indicators of corporate tech- nological strength 显示文摘Narin F Noma E Perry R 1987Research Policy1987,16,24:1
5Patents as indicators of cor- porate technological strength 显示文摘Narin F Noma E Perry R 1987Research Policy1987,16,2:1
6Patents as indicators of corporate technological strength 显示文摘Narin F Noma E Perry R 1987Research Policy1987,16,24:1
7A randomized,double-blind,multicenter comparison of the efficacy and tolerabili-ty of Restylane versus Zyplast for the correction of nasolabial folds显示文摘NARINS R S BRANDT F LEYDEN J 2003Dermatol Surg2003,29,6:1
8Effect of cooling rate on the structure and mechanical properties of milk fat and lard显示文摘Campos R Narine S S Marangoni A G 0,,10:1
9Patents as indicators of corporate technological strength 显示文摘Narin F Noma E Perry R 1987Research Policy1987,16,1:1
10Overtreatment Effects Associated with a Radiofrequency Tissue Tightening Device;Rare,Preventable,and Correctable with Subcision and Autolo-gous Fat Transfer显示文摘NARINS R S TOPE W D POPE K 2006Dennatol Surg2006,32,1:1
11Patents as indicators of corporate technological strength 显示文摘NARIN F NOMA E PERRY R 1987Research Policy1987,16,:1
12Patents as Indicators of CorporateTechnological Strength显示文摘F Narin E Noma R Perry 1987Research Policy1987,16,24:1
13Patents as indicators of corporate technological strength显示文摘NARIN F NOMA E PERRY R 1987Research Policy1987,,16:1
14In-hospital morality among women undergoing percutaneous coronary intervention: a reexamination of the gender gap显示文摘NARINS C R LING F S FISCHI M 2006Clin Cardiol2006,29,:1
15Patents as indicators of corporate technological strength 显示文摘Narin F Noma E Perry R 1987Research Policy1987,16,:1
16Patents as indicators of corporate technological strength 显示文摘Narin F Noma E Perry R 1987Research policy1987,16,2:1
17Biotechnological approaches for the production of polyhydroxyalkanoates in microorganisms and plants-a review 显示文摘Suriyamongkol P Weselake R Narine S Moloney M Shah S 2007Biotechnology Advances2007,25,2:1
18Patents as indicators of cor- porate technological strength显示文摘NARIN F NOMA E PERRY R 1987Res Policy1987,23,2:1
19The effect of minor components on milk fat crystallization 显示文摘Wright A Hartel R Narine S S 2000Journal of the American Oil Chemists'' Society2000,77,5:1
20Persistence of nasolabial fold correction with a hyaluronie acid dermal filler with retreatment: results of an 18-month extension study显示文摘NARINS R S BRANDT F S DAYAN SIt 2011Dermatol Surg2011,37,5:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费